Kunihara Takashi, Wendler Olaf, Heinrich Kerstin, Nomura Ryota, Schäfers Hans-Joachim
Department of Cardiovascular Surgery, The Cardiovascular Institute, Tokyo, Japan.
Department of Cardiothoracic Surgery, King's College Hospital, London, United Kingdom of Great Britain and Northern Ireland.
Thorac Cardiovasc Surg. 2019 Sep;67(6):428-436. doi: 10.1055/s-0038-1660518. Epub 2018 Jun 20.
The optimal choice of conduit and configuration for coronary artery bypass grafting (CABG) in diabetic patients remains somewhat controversial, even though arterial grafts have been proposed as superior. We attempted to clarify the role of complete arterial revascularization using the left internal thoracic artery (LITA) and the radial artery (RA) alone in "T-Graft" configuration on long-term outcome.
From 1994 to 2001, 104 diabetic patients with triple vessel disease underwent CABG using LITA/RA "T-Grafts" (Group-A). Using propensity-score matching, 104 patients with comparable preoperative characteristics who underwent CABG using LITA and one sequential vein graft were identified (Group-V). Freedom from all causes of death, cardiac death, major adverse cardiac event (MACE), major adverse cardiac (and cerebral) event (MACCE), and repeat revascularization at 10 years of Group-A was 60 ± 5%, 67 ± 5%, 48 ± 5%, 37 ± 5%, and 81 ± 4%, respectively, compared with 58 ± 5%, 70 ± 5%, 49 ± 5%, 39 ± 5%, and 93 ± 3% in Group-V. There were no significant differences in these end points between groups regardless of insulin-dependency. Multivariable Cox proportional hazards model identified age, left ventricular ejection fraction, renal failure, and hyperlipidemia as independent predictors for all death, age and left ventricular ejection fraction for cardiac death, sinus rhythm for both MACE and MACCE, and prior percutaneous coronary intervention for re-revascularization.
In our experience, complete arterial revascularization using LITA/RA "T-Grafts" does not provide superior long-term clinical benefits for diabetic patients compared with a combination of LITA and sequential vein graft.
尽管动脉移植物被认为更具优势,但糖尿病患者冠状动脉旁路移植术(CABG)中移植物和构型的最佳选择仍存在一定争议。我们试图阐明单独使用左内乳动脉(LITA)和桡动脉(RA)以“T型移植物”构型进行完全动脉血运重建对长期预后的作用。
1994年至2001年,104例患有三支血管病变的糖尿病患者接受了使用LITA/RA“T型移植物”的CABG(A组)。通过倾向评分匹配,确定了104例术前特征相似且接受了使用LITA和一支序贯静脉移植物的CABG的患者(V组)。A组在10年时全因死亡、心源性死亡、主要不良心脏事件(MACE)、主要不良心脏(和脑部)事件(MACCE)及再次血运重建的无事件生存率分别为60±5%、67±5%、48±5%、37±5%和81±4%,而V组分别为58± 5%、70±5%、49±5%、39±5%和93±3%。无论是否依赖胰岛素,两组间这些终点指标均无显著差异。多变量Cox比例风险模型确定年龄、左心室射血分数、肾衰竭和高脂血症是全因死亡的独立预测因素,年龄和左心室射血分数是心源性死亡的独立预测因素,窦性心律是MACE和MACCE的独立预测因素,既往经皮冠状动脉介入治疗是再次血运重建的独立预测因素。
根据我们的经验,与LITA和序贯静脉移植物联合使用相比,使用LITA/RA“T型移植物”进行完全动脉血运重建并未为糖尿病患者带来更优的长期临床获益。